• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prognostic significance of Glasgow prognostic score in patients with stage II colorectal cancer.格拉斯哥预后评分对Ⅱ期结直肠癌患者的预后意义
Int J Clin Exp Med. 2015 Oct 15;8(10):19138-43. eCollection 2015.
2
Prognostic Value of C-Reactive Protein, Glasgow Prognostic Score, and C-Reactive Protein-to-Albumin Ratio in Colorectal Cancer.C反应蛋白、格拉斯哥预后评分及C反应蛋白与白蛋白比值在结直肠癌中的预后价值
Front Cell Dev Biol. 2021 Oct 26;9:637650. doi: 10.3389/fcell.2021.637650. eCollection 2021.
3
[Predictive value of Glasgow prognostic score in patients with colorectal cancer undergoing laparoscopic radical resection].[格拉斯哥预后评分对接受腹腔镜根治性切除术的结直肠癌患者的预测价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Oct 25;19(10):1133-1138.
4
Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.基于炎症的预后系统预测术前癌胚抗原正常的结直肠癌患者的术后生存。
Ann Surg Oncol. 2012 Oct;19(11):3422-31. doi: 10.1245/s10434-012-2384-5. Epub 2012 May 11.
5
Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer.基于炎症的预后评分是结直肠癌患者术后结局的一种新型预测指标。
Ann Surg. 2007 Dec;246(6):1047-51. doi: 10.1097/SLA.0b013e3181454171.
6
Significance of the Glasgow Prognostic Score as a prognostic indicator for lung cancer surgery.格拉斯哥预后评分作为肺癌手术预后指标的意义。
Interact Cardiovasc Thorac Surg. 2015 Nov;21(5):637-43. doi: 10.1093/icvts/ivv223. Epub 2015 Aug 12.
7
The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.术前C反应蛋白/白蛋白比值在卵巢癌中的预后价值
BMC Cancer. 2017 Apr 21;17(1):285. doi: 10.1186/s12885-017-3220-x.
8
Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer.评估一种基于炎症的预后评分系统,用于识别II期结直肠癌术后需要辅助化疗的患者。
Exp Ther Med. 2011 Jan;2(1):95-101. doi: 10.3892/etm.2010.175. Epub 2010 Dec 2.
9
Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.格拉斯哥预后评分(GPS)与改良格拉斯哥预后评分(mGPS)在评估可手术和不可手术非小细胞肺癌患者预后中的比较
J Cancer Res Clin Oncol. 2016 Jun;142(6):1285-97. doi: 10.1007/s00432-015-2113-0. Epub 2016 Feb 11.
10
Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.基于炎症的预后系统可预测术前血清癌胚抗原和鳞状细胞癌抗原水平正常的食管癌患者的术后生存率。
World J Surg Oncol. 2016 May 5;14:141. doi: 10.1186/s12957-016-0878-5.

引用本文的文献

1
Predictive Value of Preoperative Fibrinogen and Albumin Score (FA Score) for Prognosis and Chemotherapeutic Efficacy in Resected Colorectal Cancer: A Retrospective Cohort Study.术前纤维蛋白原和白蛋白评分(FA评分)对根治性结直肠癌预后及化疗疗效的预测价值:一项回顾性队列研究
J Cancer. 2024 Sep 23;15(18):5968-5977. doi: 10.7150/jca.100674. eCollection 2024.
2
Preoperative inflammatory response as prognostic factor of patients with colon cancer.术前炎症反应作为结肠癌患者的预后因素。
Langenbecks Arch Surg. 2019 Sep;404(6):731-741. doi: 10.1007/s00423-019-01811-z. Epub 2019 Aug 29.
3
Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients.格拉斯哥预后评分在结直肠癌中的预后价值:对9839例患者的荟萃分析
Cancer Manag Res. 2018 Dec 24;11:229-249. doi: 10.2147/CMAR.S185350. eCollection 2019.
4
Combined fibrinogen and neutrophil-lymphocyte ratio as a predictive factor in resectable colorectal adenocarcinoma.纤维蛋白原与中性粒细胞-淋巴细胞比值联合作为可切除结直肠癌的预测因素
Cancer Manag Res. 2018 Nov 26;10:6285-6294. doi: 10.2147/CMAR.S161094. eCollection 2018.
5
A new dimensional-reducing variable obtained from original inflammatory scores is highly associated to morbidity after curative surgery for colorectal cancer.从原始炎症评分中获得的一个新的降维变量与结直肠癌根治性手术后的发病率高度相关。
Int J Colorectal Dis. 2018 Sep;33(9):1225-1234. doi: 10.1007/s00384-018-3100-0. Epub 2018 Jun 20.
6
Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.右侧结肠癌与左侧结肠癌患者血小板与淋巴细胞比值的临床基线和预后差异。
BMC Cancer. 2017 Dec 20;17(1):873. doi: 10.1186/s12885-017-3862-8.
7
Clinical and Prognostic Significance of Pathological and Inflammatory Markers in Mucinous Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy and Curative Surgery.接受新辅助放化疗和根治性手术的黏液性直肠癌患者病理和炎症标志物的临床和预后意义。
Med Sci Monit. 2017 Oct 8;23:4826-4833. doi: 10.12659/msm.904116.
8
Systemic immune-inflammation index for predicting prognosis of colorectal cancer.全身免疫炎症指数预测结直肠癌预后。
World J Gastroenterol. 2017 Sep 14;23(34):6261-6272. doi: 10.3748/wjg.v23.i34.6261.
9
Prognostic role of Glasgow prognostic score in patients with colorectal cancer: evidence from population studies.格拉斯哥预后评分在结直肠癌患者中的预后作用:来自人群研究的证据。
Sci Rep. 2017 Jul 21;7(1):6144. doi: 10.1038/s41598-017-06577-2.

本文引用的文献

1
Elevated serum level of carbohydrate antigen 19-9 in benign biliary stricture diseases can reduce its value as a tumor marker.良性胆管狭窄疾病中血清糖类抗原19-9水平升高会降低其作为肿瘤标志物的价值。
Int J Clin Exp Med. 2014 Mar 15;7(3):744-50. eCollection 2014.
2
Elevated pre-treatment levels of high sensitivity C-reactive protein as a potential prognosticator in patients with colorectal cancer.高敏C反应蛋白预处理水平升高作为结直肠癌患者的潜在预后指标。
Exp Ther Med. 2013 Dec;6(6):1369-1374. doi: 10.3892/etm.2013.1350. Epub 2013 Oct 16.
3
Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma.比较基于炎症的预后评分系统在肝细胞癌患者中的预后价值。
Br J Cancer. 2012 Sep 4;107(6):988-93. doi: 10.1038/bjc.2012.354. Epub 2012 Aug 9.
4
Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer.比较不同炎症因子在胰腺癌患者中的预后价值。
Med Oncol. 2012 Dec;29(5):3092-100. doi: 10.1007/s12032-012-0226-8. Epub 2012 Apr 5.
5
Pretreatment serum C-reactive protein level predicts poor prognosis in patients with hepatocellular carcinoma.预处理血清 C 反应蛋白水平可预测肝细胞癌患者的预后不良。
Med Oncol. 2012 Dec;29(4):2800-8. doi: 10.1007/s12032-012-0220-1. Epub 2012 Mar 30.
6
Use of inflammatory markers to guide cancer treatment.使用炎症标志物指导癌症治疗。
Clin Pharmacol Ther. 2011 Sep;90(3):475-8. doi: 10.1038/clpt.2011.122. Epub 2011 Jul 20.
7
Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer.术前血清 C 反应蛋白升高是胃癌的独立预后指标。
Surg Today. 2011 Apr;41(4):510-3. doi: 10.1007/s00595-009-4297-x. Epub 2011 Mar 23.
8
Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer.错配修复、KRAS 和 BRAF 突变在预测结直肠癌复发和化疗获益中的价值。
J Clin Oncol. 2011 Apr 1;29(10):1261-70. doi: 10.1200/JCO.2010.30.1366. Epub 2011 Mar 7.
9
Low preoperative serum albumin in colon cancer: a risk factor for poor outcome.结直肠癌患者术前低血清白蛋白:预后不良的危险因素。
Int J Colorectal Dis. 2011 Apr;26(4):473-81. doi: 10.1007/s00384-010-1113-4. Epub 2010 Dec 29.
10
Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein.提高 C-反应蛋白在肾细胞癌术前生存预测中的准确性。
Br J Cancer. 2010 Nov 23;103(11):1649-56. doi: 10.1038/sj.bjc.6605973. Epub 2010 Nov 9.

格拉斯哥预后评分对Ⅱ期结直肠癌患者的预后意义

Prognostic significance of Glasgow prognostic score in patients with stage II colorectal cancer.

作者信息

Lin Mao-Song, Huang Jun-Xing, Yu Hong

机构信息

Department of Gastroenterology, Taizhou People's Hospital Taizhou, Jiangsu Province, P. R. China.

Department of Oncology, Taizhou People's Hospital Taizhou, Jiangsu Province, P. R. China.

出版信息

Int J Clin Exp Med. 2015 Oct 15;8(10):19138-43. eCollection 2015.

PMID:26770545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4694445/
Abstract

Glasgow prognostic score (GPS), one information based prognostic score, has been previously shown to be a prognostic factor in varieties cancers mostly in advanced tumors. This study aimed to explore its value in patients with relatively early stage colorectal cancer (CRC). A total of 99 CRC patients with stage II from 2005 to 2010 operated in our hospital were enrolled in this study. C-reactive protein (CRP), albumin (ALB), Karnofsky Performance Status (KPS) score as well as a variety of biochemical variables before the operation was acquired from the database retrospectively. The value of GPS was calculated and its association with the clinical factors was further investigated. The prognostic significance was analyzed by univariate and multivariate analyses. Increased preoperative GPS was found associated with elevated carcinoembryonic antigen (CEA) and decreasing of KPS. Kaplan-Meier analysis and log-rank test revealed that a higher GPS predicted a higher risk of postoperative mortality in stage II CRC (P < 0.001). Furthermore, multivariate analysis demonstrated the GPS to be a risk factor for postoperative mortality (HR 3.215; P=0.025). The preoperative GPS might be a potential useful indicator for postoperative survival in patients with stage II CRC.

摘要

格拉斯哥预后评分(GPS)是一种基于信息的预后评分,此前已被证明是多种癌症(主要是晚期肿瘤)的预后因素。本研究旨在探讨其在相对早期结直肠癌(CRC)患者中的价值。本研究纳入了2005年至2010年在我院接受手术的99例II期CRC患者。回顾性地从数据库中获取术前的C反应蛋白(CRP)、白蛋白(ALB)、卡诺夫斯基功能状态(KPS)评分以及各种生化变量。计算GPS的值,并进一步研究其与临床因素的关联。通过单因素和多因素分析来分析预后意义。发现术前GPS升高与癌胚抗原(CEA)升高和KPS降低相关。Kaplan-Meier分析和对数秩检验显示,较高的GPS预示着II期CRC患者术后死亡风险较高(P < 0.001)。此外,多因素分析表明GPS是术后死亡的危险因素(HR 3.215;P = 0.025)。术前GPS可能是II期CRC患者术后生存的一个潜在有用指标。